Drug firm Divi's Laboratories today reported 7.62 per cent decline in its net profit to Rs 206.78 crore for the second quarter ended September 30, 2017.
The company had posted a net profit of Rs 223.85 crore in the same period of previous fiscal.
The company's revenue from operations declined to Rs 890.20 crore as against Rs 1,005.43 crore during the same period of previous fiscal, Divi's Laboratories said in a regulatory filing.
Shares of the company today ended 1.02 per cent up at Rs 881.25 on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
